Principal Street Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Principal Street Partners's GILD Position: Q1 2026 in Review
Principal Street Partners reduced its Gilead Sciences (GILD) stake by 9.1% in Q1 2026, selling an estimated $829K and leaving 58,971 shares worth $8.22M. The position accounts for 1.34% of the portfolio, ranked #17.
Principal Street Partners first reported a position in GILD in Q4 2019 and has held it in 26 quarters since. The position peaked at $9.19M in Q2 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Principal Street Partners held 58,971 shares of Gilead Sciences worth $8.22M as of Q1 2026.
- Principal Street Partners sold 5,919 Gilead Sciences shares in Q1 2026, an estimated $829K.
- Gilead Sciences made up 1.34% of Principal Street Partners's portfolio in Q1 2026, its #17 holding.
- Principal Street Partners first reported a position in Gilead Sciences in Q4 2019 and has held it in 26 quarters since.
- Principal Street Partners's Gilead Sciences position peaked at $9.19M in Q2 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Principal Street Partners's 13F filing for Q1 2026, filed 15 May 2026.